Trial Profile
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Jan 2023
Price :
$35
*
At a glance
- Drugs Lenabasum (Primary)
- Indications Cystic fibrosis
- Focus Therapeutic Use
- Sponsors Corbus Pharmaceuticals
- 25 Mar 2021 Status changed from active, no longer recruiting to completed.
- 14 Nov 2020 This trial has been completed in Netherlands according to European Clinical Trials Database record.
- 27 Oct 2020 This trial has been completed in Poland, according to European Clinical Trials Database record.